Taken together, our data suggest that the fusions (both fusion/ITS+ and fusion/ITS−) not only can be used to distinguish ALT+ cells from TEL+ cells; they could also be useful for differentiating the subgroups of ALT+ cancers. This evidence concerns the gene ETV6 and cancer.